We highlighted that PN is an underestimated problem among PwPD, especially among those receiving LCIG infusion
The FDA has approved these agents for type 2 diabetes management (not type 1 diabetes or diabetic ketoacidosis), with select formulations also approved for chronic weight management in adults with obesity or overweight with weight-related comorbidities
In fact, perhaps even more so, despite the fact we typically eat less than a teaspoon a day (~1.5 grams) of these precious plant actives in comparison with more than 50 grams of each of the macronutrients (protein, carbohydrates, and fats) (2)
Participants in discontinuation trials regained an average of 6-7 pounds per month during this period
These agents require careful dose titrations due to their adverse drug event (ADE) profile, which commonly includes nausea and vomiting
We rate sweetness on a scale of 1 to 5, based on how strong the sweetness is